Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Colomer

Showing results (71-80 of 76) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 76 results.
Breast Cancer Research : BCR|November 12, 2020
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trialMiguel Quintela-Fandino, Esther Holgado, Luis Manso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast CancerMiguel Quintela-Fandino, Begoña Bermejo, Esther Zamora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2016
<sup>18</sup>F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized TrialMiguel Quintela-Fandino, Ana Lluch, Luis Manso, et al.
Nature Communications|August 31, 2018
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancerIvana Zagorac, Sara Fernandez-Gaitero, Renske Penning, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2009
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patientsVicente Alberola Candel, Alfredo Carrato Mena, Eduardo Díaz-Rubio García, et al.
Cancer Treatment Reviews|January 15, 2017
Strategies to design clinical studies to identify predictive biomarkers in cancer researchJose Luis Perez-Gracia, Miguel F Sanmamed, Ana Bosch, et al.
Pageof 8

Showing results (71-80 of 76) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 76 results.
Breast Cancer Research : BCR|November 12, 2020
Immuno-priming durvalumab with bevacizumab in HER2-negative advanced breast cancer: a pilot clinical trialMiguel Quintela-Fandino, Esther Holgado, Luis Manso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 16, 2024
High Mechanical Conditioning by Tumor Extracellular Matrix Stiffness Is a Predictive Biomarker for Antifibrotic Therapy in HER2-Negative Breast CancerMiguel Quintela-Fandino, Begoña Bermejo, Esther Zamora, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2016
<sup>18</sup>F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized TrialMiguel Quintela-Fandino, Ana Lluch, Luis Manso, et al.
Nature Communications|August 31, 2018
In vivo phosphoproteomics reveals kinase activity profiles that predict treatment outcome in triple-negative breast cancerIvana Zagorac, Sara Fernandez-Gaitero, Renske Penning, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2009
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patientsVicente Alberola Candel, Alfredo Carrato Mena, Eduardo Díaz-Rubio García, et al.
Cancer Treatment Reviews|January 15, 2017
Strategies to design clinical studies to identify predictive biomarkers in cancer researchJose Luis Perez-Gracia, Miguel F Sanmamed, Ana Bosch, et al.
Pageof 8